Sign In
Buy XPHYF
$0.284
+0 (+0%)
At Close: Apr 17, 2023
XPhyto Therapeutics adds top-level executive talent to lead commercialization of its Covid-ID Lab
08:44am, Tuesday, 20'th Apr 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) has announced the appointment of Wolfgang Probst as its chief operations officer and the addition of Manfred Buchberger as head of corporate
XPhyto adds Top-Level Executive Talent to its Global Operations
03:05am, Tuesday, 20'th Apr 2021
VANCOUVER, BC / ACCESSWIRE / April 20, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") is pleased to announce the appointment of Mr. Wolfgang Probst as th
XPhyto Therapeutics Corp. Featured in Syndicated Broadcast Covering Recent European Approval of 25-Minute COVID-19 PCR Test
08:30am, Monday, 29'th Mar 2021
VANCOUVER, British Columbia, March 29, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- XPhyto Therapeutics Corp. (CSE: XPHY) (OTCQB: XPHYF) (FSE: 4XT), a bioscience accelerator focused on next-generation
XPhyto Therapeutics announces EU approval for coronavirus test
08:38am, Thursday, 18'th Mar 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCMKTS:XPHYF) (FRA:4XT) said its German diagnostics development partner, 3a-diagnostics GmbH has announced that its point-of-care coronavirus (COVID-19) RT-PCR te
XPhyto Therapeutics and German partner announce successful quality certification for the Covid-ID Lab
09:07am, Wednesday, 10'th Mar 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) FRA:4XT) and its German diagnostics development partner 3a-diagnostics GmbH have announced successful EN ISO 13485 certification for the rapid point-o
XPhyto Partner Receives ISO Certification for 25-Minute COVID-19 RT-PCR Test
03:05am, Wednesday, 10'th Mar 2021
VANCOUVER, BC / ACCESSWIRE / March 10, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY / OTCQB:XPHYF / FSE:4XT) ("XPhyto" or the "Company"), and its exclusive German diagnostics development partner, 3a-dia
Emerging Markets Report: A Psychedelic Story
07:07am, Tuesday, 09'th Mar 2021
An Emerging Markets Sponsored Commentary
XPhyto Therapeutics completes corporate rebranding, launches new website
09:44am, Thursday, 04'th Mar 2021
XPhyto Therapeutics Corp. (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) said it has completed a corporate rebranding and launched a new website which can be viewed at: www.xphyto.com. The company said the rebran
XPhyto Completes Corporate Rebranding and Launches New Website
03:05am, Thursday, 04'th Mar 2021
VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company"), is pleased to announce that the Company has completed a corporate r
XPhyto Provides Updated Comments on Promotional and Marketing Activity
08:20pm, Friday, 26'th Feb 2021
V ANCOUVER, BC / ACCESSWIRE / February 26, 2021 / XPhyto Therapeutics Corp. (CSE :XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Company") at the request of IIROC and the Canadian Securities Exchange (
Emerging Markets Report: Rapid Results
07:07am, Thursday, 25'th Feb 2021
An Emerging Markets Sponsored Commentary An Emerging Markets Sponsored Commentary
XPhyto Therapeutics reports first order for its rapid coronavirus RT-PCR tests
08:23am, Wednesday, 24'th Feb 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) has received the first order for its rapid coronavirus (COVID-19) RT-PCR test system (Covid-ID Lab), which is expected to be delivered by m
XPhyto Therapeutics eyeing Europe sales launch of its coronavirus RT-PCR test in April this year
08:37am, Monday, 22'nd Feb 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) is eying an initial sales launch in Europe of its coronavirus (COVID-19) RT-PCR test system (Covid-ID Lab) in April this year, it said Monda
XPhyto Reports Vektor Pharma GMBH Lawsuit
05:30pm, Friday, 19'th Feb 2021
VANCOUVER, BC / ACCESSWIRE / February 19, 2021 / XPhyto Therapeutics Corp. (CSE:XPHY)(OTCQB:XPHYF)(FSE:4XT) ("XPhyto" or the "Corporation") is providing the following comments regarding a claim mad
XPhyto Therapeutics touts completion of European regulatory application process for rapid coronavirus test
08:32am, Tuesday, 16'th Feb 2021
XPhyto Therapeutics Corp (CSE:XPHY) (OTCQB:XPHYF) (FRA:4XT) announced Tuesday that all steps required for the European regulatory application for the company's rapid point-of-care coronavirus (COVID-1
